Artificial intelligence for predicting interstitial fibrosis and tubular atrophy using diagnostic ultrasound imaging and biomarkers.
Journal:
BMJ health & care informatics
PMID:
40097202
Abstract
BACKGROUND: Chronic kidney disease (CKD) is a global health concern characterised by irreversible renal damage that is often assessed using invasive renal biopsy. Accurate evaluation of interstitial fibrosis and tubular atrophy (IFTA) is crucial for CKD management. This study aimed to leverage machine learning (ML) models to predict IFTA using a combination of ultrasonography (US) images and patient biomarkers.